ANGIODYNAMICS, INC

AngioDynamics, Inc. is a medical device manufacturer specializing in innovative interventional oncology and peripheral vascular disease treatment solutions. The company develops and markets advanced percutaneous medical devices and systems designed to improve patient outcomes in two primary clinical areas: cardiovascular disease management and cancer treatment. Key product platforms include the Auryon System, a peripheral atherectomy device for treating arterial lesions and peripheral artery disease; the AlphaVac System, designed for efficient clot removal from large vessels; and the NanoKnife System, a precision ablation platform for oncologic and cardiac applications. These systems leverage advanced technologies including irreversible electroporation, mechanical thrombectomy, and minimally invasive atherectomy. The company is committed to clinical evidence generation, with active research and clinical studies demonstrating safety and efficacy. AngioDynamics serves interventional radiologists, interventional cardiologists, and surgical oncologists across hospital and outpatient settings. The organization emphasizes partnerships in care and maintaining a talented workforce dedicated to advancing medical innovation. Based in Glens Falls, New York, AngioDynamics operates as a publicly traded medical device innovator focused on expanding treatment options and developing care pathways for cardiovascular and oncologic patient populations.